Patient Acceptance, Ease of Use, and Preference for Norditropin NordiFlex with NordiFlex PenMate: Results from an Open-Label, User Survey of Everyday Use

Table 1

Patient demographic characteristics at baseline.

Characteristic
Age (years), mean (SD)	11.27±3.95
Sex (male/female), %	47/38 (55.4/44.6)
Height (cm), mean (SD)	139.5 (29.3)
Weight (kg), mean (SD)	36.3 (18.3)
Body mass index (kg/m^2), mean (SD)	12.4 (4.9)
Diagnosis (n), (%)
GHD	28 (32.9%)
Acquired GHD	9 (10.6%)
SGA	23 (27.0%)
Turner syndrome	11 (12.9%)
“Other”	14 (16.5%)
Previous GH therapy (n), (%)
GH-naïve	19 (22.4%)
Switched from another GH device	66 (77.6%)

GH: growth hormone; GHD: growth hormone deficiency; SD: standard deviation; SGA: small for gestational age.